EMEA-001334-PIP01-12 - paediatric investigation plan

Ivermectin

Key facts

• Active Substance:
  Ivermectin
• Therapeutic area:
  Dermatology
• Decision number:
  P/0298/2012
• PIP number:
  EMEA-001334-PIP01-12
• Pharmaceutical form(s):
  Cream
• Condition(s) / indication(s):
  Treatment of rosacea
• Route(s) of administration:
  Cutaneous use
• Contact for public enquiries:

  Galderma R&D

  France; E-mail: [e-mail] ; Tel. [phone]; Fax [phone]

• Decision type:
  W: decision granting a waiver in all age groups for all conditions or indications
• Decision date:
  18/12/2012

Decision

P/0298/2012: EMA decision of 18 December 2012 on the granting of a product-specific waiver for ivermectin (EMEA-001334-PIP01-12)

AdoptedReference Number: EMA/736952/2012